Keros Therapeutics Overview
Keros Therapeutics Discounted Cash Flow
DCF Analysis for KROS.
Get informed when a big investor buys or sells
+ FollowFair Value
$13.60
Current Fair Value
$13.60
↑ 32.8% Upside
Undervalued by 32.8% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison